NEW YORK, May 15, 2025--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, ...
OST has been announced. Two versions will be released, with a limited edition including three discs worth of K.K. Slider songs. The standard edition will come with a total of four CDs, which feature a ...
OS Therapies, a clinical-stage immunotherapy and antibody drug conjugate (ADC) biopharmaceutical company, announced the launch of OS Animal Health, Inc., a wholly owned subsidiary focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results